162 related articles for article (PubMed ID: 25722344)
1. Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality.
Elkin LL; Harden DG; Saldanha S; Ferguson H; Cheney DL; Pieniazek SN; Maloney DP; Zewinski J; O'Connell J; Banks M
J Biomol Screen; 2015 Jun; 20(5):577-87. PubMed ID: 25722344
[TBL] [Abstract][Full Text] [Related]
2. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
3. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
[TBL] [Abstract][Full Text] [Related]
4. Pooling in high-throughput drug screening.
Kainkaryam RM; Woolf PJ
Curr Opin Drug Discov Devel; 2009 May; 12(3):339-50. PubMed ID: 19396735
[TBL] [Abstract][Full Text] [Related]
5. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
6. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
7. Comparison of compound administration methods in biochemical assays: effects on apparent compound potency using either assay-ready compound plates or pin tool-delivered compounds.
Smith T; Ho PI; Yue K; Itkin Z; MacDougall D; Paolucci M; Hill A; Auld DS
J Biomol Screen; 2013 Jan; 18(1):14-25. PubMed ID: 22904199
[TBL] [Abstract][Full Text] [Related]
8. Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening.
Honarnejad S; van Boeckel S; van den Hurk H; van Helden S
SLAS Discov; 2021 Feb; 26(2):192-204. PubMed ID: 32734803
[TBL] [Abstract][Full Text] [Related]
9. Stratified high-throughput screening sets enable flexible screening strategies from a single plated collection.
Nissink JW; Schmitt S; Blackburn S; Peters S
J Biomol Screen; 2014 Mar; 19(3):369-78. PubMed ID: 23918919
[TBL] [Abstract][Full Text] [Related]
10. Improving detection of rare biological events in high-throughput screens.
Murie C; Barette C; Button J; Lafanechère L; Nadon R
J Biomol Screen; 2015 Feb; 20(2):230-41. PubMed ID: 25190066
[TBL] [Abstract][Full Text] [Related]
11. The evolution of library design: crafting smart compound collections for phenotypic screens.
Spear KL; Brown SP
Drug Discov Today Technol; 2017 Mar; 23():61-67. PubMed ID: 28647087
[TBL] [Abstract][Full Text] [Related]
12. Acoustic Sample Deposition MALDI-MS (ASD-MALDI-MS): A Novel Process Flow for Quality Control Screening of Compound Libraries.
Chin J; Wood E; Peters GS; Drexler DM
J Lab Autom; 2016 Feb; 21(1):204-7. PubMed ID: 26203056
[TBL] [Abstract][Full Text] [Related]
13. Screening Pools of Compounds against Multiple Endogenously Expressed Targets in a Chemoproteomics Binding Assay.
Salzer E; Nixon E; Drewes G; Reinhard F; Bergamini G; Rau C
J Lab Autom; 2016 Feb; 21(1):133-42. PubMed ID: 26169024
[TBL] [Abstract][Full Text] [Related]
14. Hypothesis testing in high-throughput screening for drug discovery.
Prummer M
J Biomol Screen; 2012 Apr; 17(4):519-29. PubMed ID: 22233646
[TBL] [Abstract][Full Text] [Related]
15. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
[TBL] [Abstract][Full Text] [Related]
16. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
[TBL] [Abstract][Full Text] [Related]
17. Compound Transfer by Acoustic Droplet Ejection Promotes Quality and Efficiency in Ultra-High-Throughput Screening Campaigns.
Dawes TD; Turincio R; Jones SW; Rodriguez RA; Gadiagellan D; Thana P; Clark KR; Gustafson AE; Orren L; Liimatta M; Gross DP; Maurer T; Beresini MH
J Lab Autom; 2016 Feb; 21(1):64-75. PubMed ID: 26077161
[TBL] [Abstract][Full Text] [Related]
18. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
[TBL] [Abstract][Full Text] [Related]
19. Overview of high-throughput screening.
Entzeroth M; Flotow H; Condron P
Curr Protoc Pharmacol; 2009 Mar; Chapter 9():Unit 9.4. PubMed ID: 22294406
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
